Brady (BRC) Small-Cap Growth Virtual Investor Conference summary
Event summary combining transcript, slides, and related documents.
Small-Cap Growth Virtual Investor Conference summary
3 Feb, 2026Business overview and strategy
Specializes in high-performance specialty adhesives and identification products for harsh environments, serving diverse end markets globally.
Product portfolio includes wire identification, specialty adhesives, labels, printers, safety signage, healthcare ID, and access badges.
No single customer accounts for more than 10% of sales; 46% of revenue is generated outside the U.S.
Competitive landscape is fragmented, with competition varying by product and geography.
Focused on innovation, with R&D spend reaching 5% of sales in the first nine months of fiscal 2024.
Financial performance and capital allocation
Achieved three consecutive record years of EPS, with 2023 EPS up 21% over the prior year.
Operating cash flow increased 32% in the first nine months of 2024 versus the prior year.
38th consecutive annual dividend increase announced; $106 million returned to shareholders in the first nine months of 2024 via buybacks and dividends.
Maintains a disciplined approach to acquisitions, focusing on adjacent technologies and products.
Strong balance sheet with $97 million net cash position and $1.3 billion in global revenue.
Product innovation and market expansion
Recent acquisitions added RFID and barcode reading technology, enhancing track-and-trace offerings.
New product launches emphasize Bluetooth connectivity and user-friendly features.
Geographic expansion targets high-growth regions like India, with ongoing investments in sales and R&D.
Specialty materials and high-value products are prioritized for growth.
Sells into 72 countries, providing downside protection and compliance advantages.
Latest events from Brady
- Pending PSS acquisition and leadership transition mark a transformational phase for growth.BRC
Sidoti Small-Cap Virtual Investor Conference18 Jun 2026 - Record EPS, double-digit sales growth, and a $1.4B acquisition drive strong outlook.BRC
Q3 202622 May 2026 - Record adjusted EPS, 11.4% sales growth, and tighter guidance amid tariff and margin pressures.BRC
Q3 202518 May 2026 - Record EPS, strong cash flow, and Gravotech acquisition support continued growth.BRC
Q4 202418 May 2026 - Q2 FY2025 Adjusted EPS up 7.5%, guidance raised, strong cash flow and margin pressure.BRC
Q2 202518 May 2026 - Adjusted EPS up 12% and sales up 13.6%, with guidance reaffirmed for fiscal 2025.BRC
Q1 202518 May 2026 - $1.4B deal expands portfolio, adds $9B TAM, and targets $25M synergies and strong EPS accretion.BRC
M&A announcement20 Apr 2026 - Raised EPS guidance after strong sales, profit, and cash flow growth; 20th straight organic gain.BRC
Q2 202613 Apr 2026 - Record earnings, robust innovation, and global expansion drive strong long-term growth outlook.BRC
Sidoti March Small-Cap Virtual Conference19 Mar 2026